Efficacy and Tolerability of N-AVD compared to BrECADD in patients with advanced Hodgkin Lymphoma (

Tender Notice

Tender Detail
Efficacy and Tolerability of N-AVD compared to BrECADD in patients with advanced Hodgkin Lymphoma (N-BRAVE)
Tendering Authority
Tender Category
Other
Publish Date
14 May 2026
Deadline
27 May 2026
Country
Poland
TenderNews Ref. No.
3089916260514-0
Document Fees
Refer Document.
EMD
Refer Document.
Tender Value
Refer Document.
« Previous Tender      Next Tender »

Some of Our Valuable Clients